Sangamo files to validate share increase; stockholder challenge; hearing Dec 12

SANGAMO THERAPEUTICS, INC

Stockholder lawsuit claims wrong voting standard for share increase; company seeks validation.
Sangamo filed Section 205 petition to validate amendment increasing authorized shares from 640M to 960M.
Vote results: 107.95M for (52% of outstanding, 92% of votes cast); both standards met.
Court of Chancery hearing scheduled Dec 12, 2024; opposition due Nov 12.
Company previously warned of going concern risk; validation needed to enable equity fundraising.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.